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Available online 22 October 2014Multiple novel simian adenoviruses have been isolated over the past
years and their potential to cross the species barrier and infect the
human population is an ever present threat. Here we describe the isola-
tion and full genome sequencing of a novel simian adenovirus (SAdV)
isolated from the urine of two independent, never co-housed, late
stage simian immunodeﬁciency virus (SIV)-infected rhesus macaques.
The viral genome sequences revealed a novel type with a unique ge-
nome length, GC content, E3 region and DNA polymerase amino acid se-
quence that is sufﬁciently distinct from all currently known human- or
simian adenovirus species to warrant classifying these isolates as a
novel species of simian adenovirus. This new species, termed Simian
mastadenovirus D (SAdV-D), displays the standard genome organiza-
tion for the genus Mastadenovirus containing only one copy of the
ﬁber gene which sets it apart from the old world monkey adenovirus
species HAdV-G, SAdV-B and SAdV-C.
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The family Adenoviridae comprises a large family of non-enveloped double strandedDNAviruses. It can be
subdivided into ﬁve genera which contain a plethora of viruses infecting a wide range of hosts includingy, Institute, Oregon Health and Science University, 505 NW185th Ave., Beaverton,
lsevier B.V. This is an open access article under the CC BY-NC-ND license
19D. Malouli et al. / Virology Reports 3 (2014) 18–29mammals, birds, ﬁsh, and amphibians (Wold and Horwitz, 2007). The genus Mastadenovirus includes 68
human types identiﬁed to date which divide into 7 known species (A–G) (Harrach et al., 2011). These
types differ greatly in their tropism and pathogenicity, but they are generally known to infect the human
respiratory-, urinary- or gastrointestinal tract or the conjunctiva causing a range ofmedical conditions includ-
ing pneumonia, croup, bronchitis, keratoconjunctivitis, gastroenteritis and cystitis (Jones et al., 2007; Lewis
et al., 2009; Louie et al., 2008; Saad et al., 1997; Treacy et al., 2010; Walsh et al., 2009; Wold and Horwitz,
2007; Wood, 1988). Adenoviral infections are usually innocuous, but can be serious in immunocompromised
patients such as AIDS patients (Echavarria, 2008). Adenovirus types isolated from great apes are most closely
related to human types and cluster together with them within the human adenovirus (HAdV) species A–F
(Roy et al., 2009). In contrast, simian adenoviruses (SAdVs) of old-worldmonkey (OWM)origin formseparate
species (A–C). Although adenoviruses are generally considered to be species speciﬁc, zoonotic infections have
been reported (Gillespie et al., 2008; Wolfe et al., 2007). The recently described human type 52 (HAdV-52),
the founding and so far only human type of the Human mastadenovirus species G (HAdV-G), was isolated
from the stool of ﬁve different patients during an outbreak of gastroenteritis in Los Angeles county (Jones
et al., 2007). Interestingly, although considered a human species, HAdV-G also includes multiple types isolat-
ed from OWM and no further types of human or great ape origin (Chiu et al., 2013; Roy et al., 2012; Wevers
et al., 2011). HAdV-52 is thus likely of monkey origin and could therefore represent a documented case of an
OWM simian adenovirus crossing the species barrier to cause disease in humans.
Besides being important human and animal pathogens, adenoviruses are also widely used as vectors in
vaccine development and gene therapy. Human adenovirus 5 (HAdV-5) is by far themost widely used vector
but it showed poor efﬁcacy in HIV-1 clinical trials (Buchbinder et al., 2008; McElrath et al., 2008) presumably
due to the fact that this type is widespread in the human population and preexisting humoral immune re-
sponses against HAdV-5 impair the immunogenicity of HAdV-5-vectored vaccines (Casimiro et al., 2003;
Catanzaro et al., 2006; McElrath et al., 2008; Priddy et al., 2008). To bypass this problem animal adenoviruses
are being developed as alternative to human vaccine vectors. Although simian adenoviruses of great ape or-
igin are preferred because they belong to the same species as their human counterpart without showing sig-
niﬁcant seroprevalence in the human population (Dicks et al., 2012) adenoviruses of OWM origin could also
conceivably be considered since they have shown the capability to naturally cross the species barrier and in-
fect human individuals.
Here we describe the isolation and full genome analysis of a novel simian adenovirus type of rhesus ma-
caque origin. Full genome analysis of our isolate using NextGen sequencing revealed a genome sequence sub-
stantially different from all previously described human and simian types and species. Therefore, we classify
our novel simian adenovirus type as a novel species of simian adenoviruses termed Simianmastadenovirus D
(SAdV-D).
2. Results
2.1. Isolation of simian adenoviruses 26296 and 23336
Rhesus macaques (RM) suffering from AIDS like symptoms demonstrate an SIV-associated expansion of
the enteric virome including the increased appearance of multiple adenoviruses in the gastrointestinal tract
(Handley et al., 2012). To determinewhether SIV-infected RM secreted novel viruses in their urinewe collect-
ed urine from several late stage SIVmac239-infected RM and spinoculated primary rhesus ﬁbroblasts with the
fresh samples. The cells were monitored in regular intervals and most samples developed owl eyed plaques
within 1–2 weeks of infection indicative of cytomegalovirus (CMV) (data no shown). This observation was
consistent with close to 100% of the animals in our cohort being naturally CMV+. However, one viral isolate
showed a different phenotype of infection (Fig. 1A)with infected cells resembling human foreskin ﬁbroblasts
infected with HAdV-5 (Rothmann et al., 1998). In a second experiment, samples were frozen prior to
spinoculation, a process that should reduce live CMV contamination, and a second viral isolate with similar
phenotype was obtained (Fig. 1B).
To examine whether these newly isolated viruses were adenoviruses, we isolated DNA from primary
rhesus ﬁbroblasts inoculated with viral isolates from the urine of late stage-SIV infected rhesus macaques
(19262, 19936, 23336, 24514 and 26296) or RhCMV strains 68-1 and UCD59 as positive RhCMV controls
and performed diagnostic PCRs with primers for RhCMV gO, for the adenovirus hexon protein (Roy et al.,
RhCMV (glycoprotein O) 
AdV (hexon protein) 
SV40 (large T antigen) 
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2dpi 9dpi 5dpi 
Fig. 1. Isolation if simian adenovirus from the urine of late stage infected rhesusmacaques. Primary rhesus ﬁbroblasts were infected with
virus isolated from the urine of rhesus macaque 26296 (A) or rhesusmacaque 23336 (B) at anMOI of 3 and phase contrast pictures were
taken 2dpi (left panel), 5dpi (middle panel) and 9dpi (right panel). (C) Total DNA was isolated from primary rhesus ﬁbroblast infected
with virus isolated form rhesus macaques 19262, 19936, 23336, 24514 and 26296 after the infection reached full CPE and the presence
of either RhCMV (gO), adenovirus (hexon) or SV40 (large T antigen) was detected by PCR using speciﬁc primers. The RhCMV laboratory
strain 68-1 and the primary RhCMV isolate UCD59 were included as positive controls for RhCMV.
20 D. Malouli et al. / Virology Reports 3 (2014) 18–292009) or, as negative control, the large T antigen of SV40 (Bergsagel et al., 1992). As shown in Fig. 1C, all virus
isolates or controls tested were negative for SV40, whereas all putative CMV isolates were positive for gO-
speciﬁc primers. RhCMV gO-speciﬁc bandswere also observed in the putative adenovirus-containing isolates,
albeit very faint. In addition, both putative adenoviruses were the only isolates that tested positive for the
hexon gene consistent with both isolates containing adenovirus sequences. We termed the two isolates
SAdV-26296 and SAdV-23336. Sequence analysis of the gO-speciﬁc PCR fragments perfectly matched
RhCMV gO in both cases consistent with RhCMV contamination in both SAdV-isolates. In addition, both
SAdVs contained a hexon gene fragment that was identical in sequence.
2.2. Genome sequencing and analysis of SAdV-23336
Although the sequences of the hexon gene fragmentswere identical between the two isolated viruses they
differed signiﬁcantly from all hexon sequences present in GenBank. To further determine the entire genome
sequence we performed a full genome analysis using next generation sequencing. Since the hexon gene se-
quences were identical between the isolates we selected only one isolate (SAdV-23336) for further analysis.
21D. Malouli et al. / Virology Reports 3 (2014) 18–29This isolate showed signiﬁcantly less RhCMV contamination (Fig. 1C). Since herpesviruses are opportunistic
pathogens and as such reactivate in the immunocompromised host, the difference in RhCMV genome copies
detected in our two isolates might reﬂect individual difference in the amount of CMV shedd by the late stage
SIV infected animals. Viral DNAwas isolated from the supernatant of infected primary rhesus ﬁbroblasts and
the isolated DNA was sequenced on an Illumina MiSeq next generation sequencer. Using Geneious 6.1.7. we
assembled the full viral genome of 32.661 bp with a 1150 fold coverage. 54.2% of our reads were speciﬁc to
SAdV-23336 whereas none of the reads could be aligned to RhCMV, indicating that the initial CMV contami-
nation was lost during passaging in tissue culture. The resulting adenovirus genome is representative of the
genusMastadenovirus with all viral genes generally found in human- or simian adenoviruses present with
the exceptions of E4orf6/7 (Fig. 2A), a viral transcription regulatory protein (Huang and Hearing, 1989;
Marton et al., 1990;Nevins, 1992; Obert et al., 1994; Raychaudhuri et al., 1990) involved in cell transformation
(Yamano et al., 1999). Closer examination of the deep sequencing data revealed only eight single nucleotide
polymorphisms (SNPs)with a frequency above 1%with the highest being only 1.7% of all reads in that position
(Fig. 2B). Since such low frequency SNPs are most likely sequencing errors rather than true polymorphisms
(Loman et al., 2012) these results indicate a very homogenous viral population rather than a mixture of dif-
ferent adenovirus strains.
2.3. Phylogenetic analysis of SAdV-23336
To establish the evolutionary relationship of this new isolate to other adenoviruses we compared the
amino acid sequence of the penton base and of the DNA polymerase to all 68 known human types as well
as all isolates of rhesus macaque (SAdV-3, SAdV-6, SAdV-7, SAdV-A1139, SAdV-A1163, SAdV-A1173, SAdV-
A1258, SAdV-A1285, SAdV-A1296, SAdV-A1312, SAdV-A1327 and SAdV-A1335), cynomolgus macaque
(SAdV-1, SAdV-48, SAdV-49 and SAdV-50), vervet monkey (SAdV-18 and SAdV-20) and olive baboon
(BaAdV-1, BaAdV-2, BaAdV-3 and BaAdV-4) origin published to date. To begin our phylogenetic analysis
we imported the predicted amino acid sequences for the penton base and the DNA polymerase of the afore-
mentioned types fromGenBank intoGeneious 6.1.7. and generated full amino acid sequence alignments using
the Geneious sequence alignment algorithm. Subsequently, amino acid distance-based unrooted neighbor-
joining trees were generated based on the alignments using Geneious Tree Builder applying the neighbor-
joiningmethod. Using titi monkey adenovirus (TMAdV) isolated from aNWMas an outgroup, bootstrap anal-
ysis with 100 resamplings from the aligned sequences was applied to test the validity of the tree topology
followed by distance matrix calculations and calculation of the most probable consensus tree with a support
threshold of 50%. The resulting phylogenetic trees based on all penton base (Fig. 3A) or DNA polymerase
(Fig. 3B) sequences resulted in each type grouping into the expected species thus supporting our analysis
method. However, when the penton base or the DNA polymerase of our new isolate was included in the phy-
logenetic analysis, none of the known adenovirus species showed a close evolutionary relationship due to the
low homology of these proteins between our new isolate and all previously described adenovirus types.
Although all human and simian members of the genusMastadenovirus have the same overall genome or-
ganization, they differ in the number of encoded ﬁber genes. Amonghuman adenoviruses, the species A–E en-
code one ﬁber gene, whereas the species HAdV-F and HAdV-G contain two different ﬁber genes. Within the
OWM-derived simian adenoviruses, only types within the species SAdV-A and the non-classiﬁed types
SAdV-18 and SAdV-20 encode one ﬁber gene, whereas all members of the species SAdV-B and SAdV-C as
well as all human and simian types grouped together in the Humanmastadenovirus species HAdV-G encode
two different ﬁber genes (Fig. 4A). Similar to SAdV-A only a single copy of the ﬁber gene was encoded by the
new isolate SAdV-23336. However, the predicted amino acid sequence for the ﬁber protein was considerably
shorter compared to all types grouped in SAdV-A and exhibited very low overall identity ( 30%). In addition,
our isolate displays a unique GC content (46.7%) that is notably lower than the GC content in any other clas-
siﬁed SAdV type. Since the overall GC content is usually highly conserved betweenmembers of the same spe-
cies this indicates that SAdV-23336 is distinct from all known types and does not fall into any established
species. Similarly, the length of the E3 region encoded in the viral genome,which can be used to insert foreign
antigens in vector development, as well as the full genome length differ greatly between species, but not be-
tween types within a species. The E3 region of SAdV-23336 contains 2731 bp ranging from the start codon of
the predicted E3 12.5 kDa protein to the stop codon of the predicted E3 14.7 kDa protein. In comparison to the
other examined SAdV species, this length resembles the E3 region found in species SAdV-B, but it differs
s-
Fig. 2. Full genome sequence and ORF annotation of SAdV-23336. Viral DNA was isolated from the supernatant of SAdV-23336 infected rhesus ﬁbroblasts. Next-generation sequencing was performed
using an IlluminaMiSeq sequencer and the full genomewas assembled using Geneious 6.1.7. A) Graphical depiction of the annotated full genome sequence of SAdV-23336. B) Single nucleotide polymor-
phisms (SNPs) with an incident rate of above 1% are shown across the entire genome. Only 8 SNPs were found at low frequency none of them exceeding 1.7%.
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Fig. 3. SAdV-23336 forms a distinct phenotypic cluster when compared to known species of human-or simian adenoviruses. All 68 HAdV types known to date as well as all SAdV isolates from rhesus ma-
caques, cynomolgusmacaques, vervet monkeys or baboonswere used to create phylogenetic trees. The amino acid sequences of either the penton base (A) or the DNA polymerase (B) were aligned using
Geneious 6.1.7. and phylogenetic trees were generated using the neighbor-joining method. TMAdV was used as an outgroup.
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A) B) TMAdV
SAdV-
23336
HAdV-
52 SAdV-1 SAdV-7 SAdV-3 SAdV-6
SAdV-
48
SAdV-
18
SAdV-
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BaAdV-
1
SAdV-
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SAdV-
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SAdV-
A1139
SAdV-
A1163
SAdV-
A1173
SAdV-
A1258
SAdV-
A1285
SAdV-
A1296
SAdV-
A1312
SAdV-
A1327
SAdV-
A1335
BaAdV-
2
BaAdV-
3
BaAdV-
4
TMAdV 57.6 63.2 63.1 62.5 60.9 60.8 60.6 62.6 59.9 62.2 62.5 62.5 62.6 62.2 62.1 62.0 62.1 62.6 62.6 62.3 62.5 61.6 61.6 61.6
SAdV-
23336 57.6 68.4 68.3 68.0 65.1 65.0 64.8 66.7 64.6 66.9 66.6 66.6 66.9 66.9 66.6 66.5 66.4 67.1 67.1 67.1 67.0 68.0 67.8 68.0
HAdV-
52 63.2 68.4 98.6 97.6 69.6 69.6 69.9 79.7 68.3 75.7 76.3 76.3 75.9 76.3 74.7 74.6 74.5 75.9 75.9 76.0 75.9 84.4 84.7 84.4
SAdV-1 63.1 68.3 98.6 98.3 69.4 69.4 69.7 79.6 68.4 75.6 76.2 76.2 75.8 76.2 74.6 74.5 74.4 75.9 75.9 75.9 75.8 84.5 84.8 84.5
SAdV-7 62.5 68.0 97.6 98.3 69.3 69.2 69.5 79.0 68.3 75.4 75.8 75.8 75.5 75.9 74.2 74.1 74.0 75.6 75.6 75.7 75.5 84.3 84.6 84.3
SAdV-3 60.9 65.1 69.6 69.4 69.3 99.4 98.0 68.5 80.7 68.2 67.9 67.9 68.2 68.2 67.8 67.8 67.5 68.2 68.2 68.2 68.3 68.4 68.0 68.4
SAdV-6 60.8 65.0 69.6 69.4 69.2 99.4 97.9 68.7 80.8 68.2 67.8 67.8 68.1 68.2 67.7 67.7 67.3 68.2 68.2 68.1 68.2 68.5 68.0 68.5
SAdV-
48 60.6 64.8 69.9 69.7 69.5 98.0 97.9 68.6 80.6 68.2 68.1 68.1 68.2 68.5 67.9 67.9 67.6 68.2 68.2 68.5 68.2 68.7 68.1 68.7
SAdV-
18 62.6 66.7 79.7 79.6 79.0 68.5 68.7 68.6 67.1 76.0 76.3 76.3 76.5 76.1 74.9 74.8 74 .5 76.6 76.6 76.2 76.5 77.9 77.5 77.9
SAdV-
20 59.9 64.6 68.3 68.4 68.3 80.7 80.8 80.6 67.1 66.6 66.7 66.7 66.7 66.7 65.3 65.3 65.3 66.7 66.7 66.7 66.7 67.6 67.3 67.6
BaAdV-
1 62.2 66.9 75.7 75.6 75.4 68.2 68.2 68.2 76.0 66.6 97.7 97.7 98.5 98.8 91.8 91.7 91.5 98.7 98.7 99.0 98.8 74.1 73.8 74.1
SAdV-
49 62.5 66.6 76.3 76.2 75.8 67.9 67.8 68.1 76.3 66.7 97.7 100.0 98.0 97.9 92.3 92.3 92.2 98.0 98.0 97.8 98.1 74.3 73.9 74.3
SAdV-
50 62.5 66.6 76.3 76.2 75.8 67.9 67.8 68.1 76.3 66.7 97.7 100.0 98.0 97.9 92.3 92.3 92.2 98.0 98.0 97.8 98.1 74.3 73.9 74.3
SAdV-
A1139 62.6 66.9 75.9 75.8 75.5 68.2 68.1 68.2 76.5 66.7 98.5 98.0 98.0 98.6 91.8 91.6 91.4 99.0 99.0 98.5 99.1 74.3 73.9 74.3
SAdV-
A1163 62.2 66.9 76.3 76.2 75.9 68.2 68.2 68.5 76.1 66.7 98.8 97.9 97.9 98.6 92.2 92.0 91.8 98.6 98.6 98.8 98.7 74.4 74.0 74.4
SAdV-
A1173 62.1 66.6 74.7 74.6 74.2 67.8 67.7 67.9 74.9 65.3 91.8 92.3 92.3 91.8 92.2 99.4 99.1 91.9 91.9 92.2 92.0 73.0 72.7 73.0
SAdV-
A1258 62.0 66.5 74.6 74.5 74.1 67.8 67.7 67.9 74.8 65.3 91.7 92.3 92.3 91.6 92.0 99.4 99.2 91.8 91.8 92.0 91.8 72.9 72.6 72.9
SAdV-
A1285 62.1 66.4 74.5 74.4 74.0 67.5 67.3 67.6 74.5 65.3 91.5 92.2 92.2 91.4 91.8 99.1 99.2 91.6 91.6 91.8 91.7 73.0 72.7 73.0
SAdV-
A1296 62.6 67.1 75.9 75.9 75.6 68.2 68.2 68.2 76.6 66.7 98.7 98.0 98.0 99.0 98.6 91.9 91.8 91.6 100.0 98.8 99.9 74.4 73.9 74.4
SAdV-
A1312 62.6 67.1 75.9 75.9 75.6 68.2 68.2 68.2 76.6 66.7 98.7 98.0 98.0 99.0 98.6 91.9 91.8 91.6 100.0 98.8 99.9 74.4 73.9 74.4
SAdV-
A1327 62.3 67.1 76.0 75.9 75.7 68.2 68.1 68.5 76.2 66.7 99.0 97.8 97.8 98.5 98.8 92.2 92.0 91.8 98.8 98.8 98.9 74.4 74.0 74.4
SAdV-
A1335 62.5 67.0 75.9 75.8 75.5 68.3 68.2 68.2 76.5 66.7 98.8 98.1 98.1 99.1 98.7 92.0 91.8 91.7 99.9 99.9 98.9 74.4 74.0 74.4
BaAdV-
2 61.6 68.0 84.4 84.5 84.3 68.4 68.5 68.7 77.9 67.6 74.1 74.3 74.3 74.3 74.4 73.0 72.9 73.0 74.4 74.4 74.4 74.4 98.0 100.0
BaAdV-
3 61.6 67.8 84.7 84.8 84.6 68.0 68.0 68.1 77.5 67.3 73.8 73.9 73.9 73.9 74.0 72.7 72.6 72.7 73.9 73.9 74.0 74.0 98.0 98.0
BaAdV-
4 61.6 68.0 84.4 84.5 84.3 68.4 68.5 68.7 77.9 67.6 74.1 74.3 74.3 74.3 74.4 73.0 72.9 73.0 74.4 74.4 74.4 74.4 100.0 98.0
Serotype Genome Size GC content E3 region Fiber Genes
TMAdV 36,838 59.6 3,546 1
SAdV-23336 32,661 46.7 2,731 1
HAdV-52 34,250 55.1 2,585 2
SAdV-1 34,450 55.2 2,582 2
SAdV-7 31,045 56.3 318 2
SAdV-3 34,246 55.3 3,256 1
SAdV-6 34,115 55.8 3,233 1
SAdV-48 34,201 54.4 3,244 1
SAdV-18 31,967 61.4 309 1
SAdV-20 34,302 47.8 3,226 1
BaAdV-1 35,537 62.7 2,744 2
SAdV-49 35,499 62.8 2,750 2
SAdV-50 35,512 62.6 2,750 2
SAdV-A1139 35,558 62.7 2,744 2
SAdV-A1163 35,580 62.0 2,756 2
SAdV-A1173 35,726 61.1 2,786 2
SAdV-A1258 35,649 61.0 2,745 2
SAdV-A1285 35,705 61.0 2,786 2
SAdV-A1296 35,499 62.6 2,733 2
SAdV-A1312 35,578 62.6 2,781 2
SAdV-A1327 35,540 62.9 2,750 2
SAdV-A1335 35,557 62.8 2,750 2
BaAdV-2 34,319 52.6 2,587 2
BaAdV-3 34,402 52.3 2,584 2
BaAdV-4 34,391 52.6 2,587 2
Fig. 4. SAdV-23336 differs substantially from known simian adenovirus types. A) Different SAdV species vary in their GC content, the length and coding content of their E3 region as well as their overall
genome size and in the number of ﬁber genes they encode. A combination of all these characteristics can be used to classify types into the species they belong to. B) A further characteristic is the level of
conservation between the DNA polymerase across species and types. The total level of identity shown as percent (%) identity between the DNA polymerase amino acid sequences of the indicated SAdV
types was determined using the same analysis as for the phylogenetic tree shown in Fig. 3A. The different shades of orange indicate different levels of identity (≥70%, ≥80%, ≥90% and ≥95%). Types
highlighted in light blue (HAdV-G), purple (SAdV-A), green (SAdV-B) and brown (SAdV-C) indicate the different analyzed species. Our novel isolate is shown in red (SAdV-D). SAdV-18 and SAdV-20
have not been classiﬁed yet, but given that these two types do not show any signiﬁcant similarity in length, number of ﬁber genes, GC content, and length of their E3-region to any other human or simian
type or to each other, it is possible that they too represent independent simian adenovirus species. The NWM simian adenovirus TMAdV was used for comparison.
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25D. Malouli et al. / Virology Reports 3 (2014) 18–29ubstantially from the E3 region found inHAdV-G, SAdV-A and SAdV-C. Furthermore, the SAdV-23336 genome
length of 32,661 bp is considerably shorter than the genomes of representative members of all other
established SAdV species. The types SAdV-7 and SAdV-18 are outliers of this general rule since their E3 region
as well as subsequently their full length genome are signiﬁcantly shorter than those of other types of human
or simian adenoviruses, but it has been noted before that this is likely due to a truncation of the viral genome
(Roy et al., 2011). Lastly, the comparison of the conserved DNApolymerase genes across all simian adenovirus
species (Fig. 4B) revealed that different types of the same species are more than 90% identical, whereas types
that belong to different species are less than 80% identical. SAdV-23336 does not sharemore than 70% identity
to any other SAdV type. Thus, the new isolate described here is signiﬁcantly different from any previously de-
ﬁned species of simian adenoviruses, indicating that SAdV-23336 might represent a new species within the
genusMastadenovirus for which we propose the name Simian mastadenovirus D (SAdV-D).3. Discussion
Wereport here on the isolation and genomic characterization of a novel simian adenovirus from secretions
of late stage SIV-infected RM. The genomic sequence of this virus differs signiﬁcantly fromany knownhuman-
or simian adenovirus suggesting that we isolated a novel species. Interestingly, the twomonkeys used to iso-
late the viruses were never co-housed suggesting that these SAdVs are widespread in our colony. The poten-
tial of this virus to infect humans is currently not known, but the recent identiﬁcation of several novel human
and simian adenoviruses and their phylogenetic analysis suggests that cross species infections among human
and non-human primatesmight occurmore frequently than previously assumed. The human adenovirus type
52was isolated in Los Angeles county during an outbreak of gastroenteritis from stool specimen of human pa-
tients (Jones et al., 2007). This virus differed substantially from the previously known human species A–F and
displayed a duplication of theﬁber gene, a genotype that is rarely found in human adenoviruses. It became the
founding member of a novel human adenovirus species termed HAdV-G, but even after years of further re-
search, no additional human or great ape type grouping into the same species could be identiﬁed. In contrast,
multiple simian types of OWMorigin exhibited high similarity to HAdV-52, so that themajority of types clus-
tering in the human species HAdV-Gwere actually isolates from rhesus- and cynomolgusmacaques, suggest-
ing that HAdV-52might have entered the human population via zoonotic infection frommonkeys (Chiu et al.,
2013; Maluquer de Motes et al., 2011; Roy et al., 2009, 2012; Wevers et al., 2011). In another example, a re-
spiratory infection that occurred in a researcher at the California National Primate Research Center (CNPRC)
during an outbreak of pneumonia and hepatitis in a colony of titi monkeys could be linked to a novel adeno-
virus (TMAdV) (Chen et al., 2011). This observation suggested that adenoviruses can leap from rather distant-
ly related new world monkeys (NWM) to humans. Moreover, human to human transmission of TMAdV was
observed in a close family member of the researcher originally infected (Chen et al., 2011). Taken together,
these observations suggest that novel adenoviruses can be contracted fromNHP and that our newly identiﬁed
OWM AdV species might represent a risk for animal caretakers.
Sequence analysis and genomic comparisons suggest that our adenovirus isolate represents a novel type of
simian adenovirus, although we did not perform any serology experiments to determine cross neutralization
with other closely related types. The low sequence homology to any known human or simian adenoviruses
further suggests that this isolate represents a novel species as well. Among the criteria used to deﬁne adeno-
virus species in the 2011 ICTV report, different species generally display a phylogenetic distance of N5–15%,
based primarily on distancematrix analysis of the DNApolymerase amino acid sequence, a genome organiza-
tion, characteristically in the E3 region, that is unique to members of a certain species and GC content that
varies greatly between different species (Harrach et al., 2011). SAdV-23336 shows no similarity in GC content
to any of the established SAdV species and only some similarity to SAdV-B when examining the length of the
E3 region and to SAdV-Awhen comparing the number of encoded ﬁber genes. In addition, the viral genome is
unusually short compared to all other SAdVs of OWM origin and lacks the control protein E4orf6/7 generally
found in primate adenoviruses. Since our isolate shows less than 70% identity (more than 30%distance) to any
other published amino acid sequence of the DNA polymerase we propose that this adenovirus represents a
novel species and type whichwill likely be conﬁrmed by future serological analysis. Given the substantial dif-
ference between our novel isolate and all other human and simian species described to datewepropose a new
species termed Simian mastadenovirus D (SAdV-D). It will be interesting to examine how widespread this
26 D. Malouli et al. / Virology Reports 3 (2014) 18–29species is disseminated among our colony of Indian-origin RMand potentially among humans in contactwith
these animals.
4. Materials and methods
4.1. Cells
Primary rhesus ﬁbroblasts were maintained in Dulbecco's modiﬁed Eagle's medium (DMEM) with 10%
fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin and were grown at 37 °C in humidiﬁed
air with 5% CO2.
4.2. Isolation of the novel simian adenoviruses
Urine was obtained from SIVmac239-infected rhesus macaques either through cystocentesis or during
necropsy. The urinewasﬁrst centrifuged at 2000 g for 10min at 4 °C to pellet all cell debris and contaminants,
and then ﬁltered through a 0.45 μm ﬁlter (Millipore) to clear the urine from any bacterial or fungal contam-
ination. Subsequently, primary rhesus ﬁbroblasts seeded out in 6 well plates were spinoculated by adding
500 μl–1000 μl of cleared urine per well and centrifugation at 700 g for 30 min at 25 °C. 2hpi the cells were
washed and new DMEM+10% fetal bovine serum and penicillin/streptomycin were added. The cells were
kept in culture for up to 1 month or until signs of viral infectionwere noticed inwhich case the cells were har-
vested at full cytopathic effect (CPE) and the virus was puriﬁed and analyzed.
4.3. SAdV puriﬁcation and stock generation
SAdV was grown on primary rhesus ﬁbroblasts until full CPE. Cells and supernatant were harvested,
pooled and frozen to release residual virus from the cells. The cellular debris was removed in two steps,
ﬁrst by centrifugation at 2000 g for 10 min at 4 °C and subsequently by centrifugation at 7500 g for 15 min.
The clariﬁed medium was layered over a sorbitol cushion (20% D-sorbitol, 50 mM Tris [pH 7.4], 1 mM
MgCl2), and virus was spun down by centrifugation at 64,000 g for 1 h at 4 °C in a Beckman SW28 rotor.
The virus pellet was resuspended in Dulbecco's modiﬁed Eagle's medium (DMEM) with 10% fetal bovine
serum, 100 U/ml penicillin, and 100 μg/ml streptomycin, aliquoted, snap frozen in liquid nitrogen and stored
at−80 °C until further use. Viral titers were determined by limited dilution assay on primary rhesus ﬁbro-
blast and CPE was determined in infected wells after 14 days.
4.4. Identiﬁcation of the novel isolates using PCR
Primary rhesus ﬁbroblasts were infectedwith viral isolates at a multiplicity of infection (MOI) of 3 and the
cells were harvested at full CPE. DNA was isolated using a DNeasy Blood & Tissue Kit (Qiagen). To test for the
presence of RhCMV, adenoviruses and SV40 the following primers were used: RhCMV gO (Sense: 5′-TGCGCA
TTGTACTTCGCAT-3′; Antisense: 5′-GTATTTATTCAACGAGACGTA-3′), a conserved region in the adenovirus
hexon protein (Sense: 5′-CAGGACGCCTCGGAGTACCTGAG-3′; Antisense: 5′-TTGGCAGGAATGGGGTACAG
CATGTT-3′) (Roy et al., 2009), the large T antigen of SV40 (Sense: 5′-GCATGACTCAAAAAACTTAGCAATTC
TG-3′; Antisense: 5′-CTTTGGAGGCTTCTGGGATGCAACT-3′) (Bergsagel et al., 1992). PCR was performed
using AccuPrime™ Taq DNA Polymerase High Fidelity (Life Technologies) following the manufacturer's in-
structions. The ampliﬁed DNA was puriﬁed on a 1% agarose gel and the isolated DNA was sent to Euroﬁns
MWG Operon (Huntsville, AL, USA) for sequencing.
4.5. Next generation sequencing of viral DNA
To purify viral DNAwemodiﬁed a protocol previously used for the extraction of viral DNA from HAdV-40
(Mautner, 2007). Primary rhesus ﬁbroblasts were infected with SAdV at an MOI of 0.1 and the supernatant
was harvested at full CPE. To remove cellular contaminants, residual cells and cell debris were removed by
centrifugation initially at 2000 g for 10 min at 4 °C and subsequently at 7500 g for 15 min. To generate a
viral pellet, the clariﬁed medium was layered over a sorbitol cushion (20% D-sorbitol, 50 mM Tris [pH 7.4],
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rotor. The virus pellet was resuspended in 500 μl 10.1 TE Buffer (10 mM Tris, pH 8.0; 0.1 mM EDTA, pH 8.0)
and 500 μl 2× Lysis Buffer (20 mM Tris–Cl, pH 8.0; 50 mM EDTA, pH 8.0; 200 mM NaCl; 1.2% w/v SDS)
were added to lyse the viral virions. Finally, 250 μg Proteinase K were added and the solution was incubated
for 2 h at 37 °C. The viral DNAwas phenol/chloroform extracted twice and precipitatedwith absolute ethanol
at−80 °C overnight. The DNAwas spun down at 16,000 g for 20min at 4 °C and washed once with 70% eth-
anol. Finally the DNAwas resuspended inwater and theDNA concentrationwas determined using a ND-1000
Spectrophotometer (NanoDrop Technologies, Inc.).
4.6. Generation of next generation sequencing libraries
The DNA was fragmented using an S2 Sonicator (Covaris) and was then converted to libraries using the
standard TruSeq protocol (Illumina). The ends of the fragmented DNAwere enzymatically blunted, then a sin-
gle terminal “A” nucleotide was added to assist ligation. Adaptors containing ﬂow cell-binding sequences, in-
dices, and primer binding sites were then ligated to the fragments. The resulting DNA was ampliﬁed using
polymerase chain reaction with a limited number of cycles. Following removal of adaptor dimers, the library
was examined on the Bioanalyzer (Agilent) and the concentration was determined using real time PCR and
SYBR Green ﬂuorescence.
4.7. Next generation sequencing
Next generation sequencing was performed using a MiSeq Next-Generation Sequencing System
(Illumina). The generated libraries were loaded into a MiSeq reagent cartridge at a concentration of 9 pM
and single read sequencingwas performed for 300 cycleswith 6 additional cycles of index reads. The resulting
data was imported into Geneious 6.1.7. and the sequencing reads were trimmed of all regions exceeding the
error probability limit of 0.1% to minimize sequencing errors. Subsequently, the genome of our viral isolate
was de novo assembled using the processed sequencing data.
4.8. Generation of phylogenetic trees and statistical analysis
Relevant predicted amino acid sequences of the adenoviral proteins of interest (penton base and DNA po-
lymerase) were imported from GenBank into Geneious 6.1.7. and amino acid sequence alignments were gen-
erated using Geneious Alignment. Phylogenetic analysis to generate amino acid distance-based unrooted
neighbor-joining trees (Saitou and Nei, 1987) was performed based on these alignments using Geneious
Tree Builder applying the neighbor-joining method. The validity of the tree topology obtained was tested
by using bootstrap analysis (Felsenstein, 1985) with 100 resamplings from the aligned sequences, followed
by distance matrix calculations and calculation of the most probable consensus tree with a support threshold
of 50%. In all shown phylogenetic trees, the NWM adenovirus TMAdV was used as an outgroup.
4.9. Viral sequences utilized in this study
The full genome sequence of the newly isolated simian adenovirus 23336 (SAdV-23336)was submitted to
GenBank (KM190146). The following adenovirus sequences published in GenBank were used in this study:
BaAdV-1 (KC693021), BaAdV-2 (KC693022), BaAdV-3 (KC693023), BaAdV-4 (KC693024), HAdV-1 (AC_
000017), HAdV-2 (AC_000007), HAdV-3 (AY599834), HAdV-4 (AY458656), HAdV-5 (AC_000008), HAdV-6
(HQ413315), HAdV-7 (AC_000018), HAdV-8 (AB448769), HAdV-9 (AJ854486), HAdV-10 (JN226746),
HAdV-11 (AF532578), HAdV-12 (X73487), HAdV-13 (JN226747), HAdV-14 (AY803294), HAdV-15
(JN226748), HAdV-16 (JN860680), HAdV-17 (HQ910407), HAdV-18 (GU191019), HAdV-19 (AB448774),
HAdV-20 (JN226749), HAdV-21 (AY601633), HAdV-22 (FJ404771), HAdV-23 (JN226750), HAdV-24
(JN226751), HAdV-25 (JN226752), HAdV-26 (EF153474), HAdV-27 (JN226753), HAdV-28 (FJ824826),
HAdV-29 (JN226754), HAdV-30 (JN226755), HAdV-31 (AM749299), HAdV-32 (JN226756), HAdV-33
(JN226758), HAdV-34 (AY737797), HAdV-35 (AY271307), HAdV-36 (GQ384080), HAdV-37 (AB448777),
HAdV-38 (JN226759), HAdV-39 (JN226760), HAdV-40 (NC_001454), HAdV-41 (DQ315364), HAdV-42
(JN226761), HAdV-43 (KC529648), HAdV-44 (JN226763), HAdV-45 (JN226764), HAdV-46 (AY875648),
28 D. Malouli et al. / Virology Reports 3 (2014) 18–29HAdV-47 (JN226757), HAdV-48 (EF153473), HAdV-49 (DQ393829), HAdV-50 (AY737798), HAdV-51
(JN226765), HAdV-52 (DQ923122), HAdV-53 (AB605244), HAdV-54 (NC_012959), HAdV-55 (JX123028),
HAdV-56 (HM770721), HAdV-57 (HQ003817), HAdV-58 (HQ883276), HAdV-59 (JF799911), HAdV-60
(HQ007053), HAdV-61 (JF964962), HAdV-62 (JN162671), HAdV-63 (JN935766), HAdV-64 (JQ326207),
HAdV-65 (AP012285), HAdV-66 (JN860676), HAdV-67 (AP012302), HAdV-68 (JN860678), SAdV-1 (NC_
006879), SAdV-3 (NC_006144), SAdV-6 (JQ776547), SAdV-7 (DQ792570), SAdV-18 (FJ025931), SAdV-20
(NC_020485), SAdV-48 (HQ241818), SAdV-49 (NC_015225), SAdV-50 (HQ241820), SAdV-A1139
(JN880448), SAdV-A1163 (JN880449), SAdV-A1173 (JN880450), SAdV-A1258 (JN880451), SAdV-A1285
(JN880452), SAdV-A1296 (JN880453), SAdV-A1312 (JN880454), SAdV-A1327 (JN880455), SAdV-A1335
(JN880456) and TMAdV (NC_020487).
Acknowledgments
This projectwas supported by theNational Center for Research Resources and theOfﬁce of Research Infra-
structure Programs (ORIP) of theNational Institutes of Health through grant P51OD011092.We are grateful to
Dr. Robert Searles and the OHSU Massively Parallel Sequencing Shared Resource (MPSSR) for generating the
NGS libraries, to Yibing Jia and theMolecular and Cellular Biology Core (MCBCore) at theOregonNational Pri-
mate Research Center (ONPRC) for analyzing the samples on their MiSeq next generation sequencer and to
Andrew Townsend for his help in the graphical design and preparation of the here presented ﬁgures.
References
Bergsagel, D.J., Finegold, M.J., Butel, J.S., Kupsky, W.J., Garcea, R.L., 1992. DNA sequences similar to those of simian virus 40 in
ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med. 326, 988–993.
Buchbinder, S.P., Mehrotra, D.V., Duerr, A., Fitzgerald, D.W., Mogg, R., Li, D., Gilbert, P.B., Lama, J.R., Marmor, M., Del Rio, C., McElrath, M.J.,
Casimiro, D.R., Gottesdiener, K.M., Chodakewitz, J.A., Corey, L., Robertson, M.N., 2008. Efﬁcacy assessment of a cell-mediated immu-
nity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881–1893.
Casimiro, D.R., Chen, L., Fu, T.M., Evans, R.K., Caulﬁeld, M.J., Davies, M.E., Tang, A., Chen, M., Huang, L., Harris, V., Freed, D.C., Wilson, K.A.,
Dubey, S., Zhu, D.M., Nawrocki, D., Mach, H., Troutman, R., Isopi, L., Williams, D., Hurni, W., Xu, Z., Smith, J.G., Wang, S., Liu, X., Guan,
L., Long, R., Trigona, W., Heidecker, G.J., Perry, H.C., Persaud, N., Toner, T.J., Su, Q., Liang, X., Youil, R., Chastain, M., Bett, A.J., Volkin,
D.B., Emini, E.A., Shiver, J.W., 2003. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus,
and replication-defective adenovirus vectors expressing a human immunodeﬁciency virus type 1 gag gene. J. Virol. 77, 6305–6313.
Catanzaro, A.T., Koup, R.A., Roederer, M., Bailer, R.T., Enama, M.E., Moodie, Z., Gu, L., Martin, J.E., Novik, L., Chakrabarti, B.K., Butman, B.T.,
Gall, J.G., King, C.R., Andrews, C.A., Sheets, R., Gomez, P.L., Mascola, J.R., Nabel, G.J., Graham, B.S., 2006. Phase 1 safety and immuno-
genicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J.
Infect. Dis. 194, 1638–1649.
Chen, E.C., Yagi, S., Kelly, K.R., Mendoza, S.P., Tarara, R.P., Canﬁeld, D.R., Maninger, N., Rosenthal, A., Spinner, A., Bales, K.L., Schnurr, D.P.,
Lerche, N.W., Chiu, C.Y., 2011. Cross-species transmission of a novel adenovirus associatedwith a fulminant pneumonia outbreak in a
new world monkey colony. PLoS Pathog. 7, e1002155.
Chiu, C.Y., Yagi, S., Lu, X., Yu, G., Chen, E.C., Liu, M., Dick Jr., E.J., Carey, K.D., Erdman, D.D., Leland, M.M., Patterson, J.L., 2013. A novel ad-
enovirus species associatedwith an acute respiratory outbreak in a baboon colony and evidence of coincident human infection.MBio
4, e00084.
Dicks, M.D., Spencer, A.J., Edwards, N.J., Wadell, G., Bojang, K., Gilbert, S.C., Hill, A.V., Cottingham, M.G., 2012. A novel chimpanzee adeno-
virus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. PLoS One 7,
e40385.
Echavarria, M., 2008. Adenoviruses in immunocompromised hosts. Clin. Microbiol. Rev. 21, 704–715.
Felsenstein, J., 1985. Conﬁdence limits on phylogenies: an approach using the bootstrap. Evolution 39, 783–791.
Gillespie, T.R., Nunn, C.L., Leendertz, F.H., 2008. Integrative approaches to the study of primate infectious disease: implications for biodi-
versity conservation and global health. Am. J. Phys. Anthropol. Suppl. 47, 53–69.
Handley, S.A., Thackray, L.B., Zhao, G., Presti, R., Miller, A.D., Droit, L., Abbink, P., Maxﬁeld, L.F., Kambal, A., Duan, E., Stanley, K., Kramer, J.,
Macri, S.C., Permar, S.R., Schmitz, J.E., Mansﬁeld, K., Brenchley, J.M., Veazey, R.S., Stappenbeck, T.S., Wang, D., Barouch, D.H., Virgin,
H.W., 2012. Pathogenic simian immunodeﬁciency virus infection is associated with expansion of the enteric virome. Cell 151,
253–266.
Harrach, B., Benkö, M., Both, G., Brown, M., Davis, A., Echavarría, M., Hess, M., Jones, M., Kajon, A., Lahmkuhl, H., Mautner, V., Mittal, S.,
Wadell, G., 2011. Family Adenoviridae. In: King, A., Adams, M., Carstens, E., Lefkowitz, E. (Eds.), Virus Taxonomy: Classiﬁcation
and Nomenclature of Viruses. Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier, San Diego, CA, pp.
95–111.
Huang, M.M., Hearing, P., 1989. The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the
cellular transcription factor, E2F, through a direct complex. Genes Dev. 3, 1699–1710.
Jones II, M.S., Harrach, B., Ganac, R.D., Gozum, M.M., Dela Cruz, W.P., Riedel, B., Pan, C., Delwart, E.L., Schnurr, D.P., 2007. New adenovirus
species found in a patient presenting with gastroenteritis. J. Virol. 81, 5978–5984.
Lewis, P.F., Schmidt, M.A., Lu, X., Erdman, D.D., Campbell, M., Thomas, A., Cieslak, P.R., Grenz, L.D., Tsaknardis, L., Gleaves, C., Kendall, B.,
Gilbert, D., 2009. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J. Infect. Dis.
199, 1427–1434.
29D. Malouli et al. / Virology Reports 3 (2014) 18–29Loman, N.J., Misra, R.V., Dallman, T.J., Constantinidou, C., Gharbia, S.E., Wain, J., Pallen, M.J., 2012. Performance comparison of benchtop
high-throughput sequencing platforms. Nat. Biotechnol. 30, 434–439.
Louie, J.K., Kajon, A.E., Holodniy, M., Guardia-LaBar, L., Lee, B., Petru, A.M., Hacker, J.K., Schnurr, D.P., 2008. Severe pneumonia due to
adenovirus serotype 14: a new respiratory threat? Clin. Infect. Dis. 46, 421–425.
Maluquer de Motes, C., Hundesa, A., Almeida, F.C., Boﬁll-Mas, S., Girones, R., 2011. Isolation of a novel monkey adenovirus reveals a new
phylogenetic clade in the evolutionary history of simian adenoviruses. Virol. J. 8, 125.
Marton, M.J., Baim, S.B., Ornelles, D.A., Shenk, T., 1990. The adenovirus E4 17-kilodalton protein complexeswith the cellular transcription
factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. J. Virol. 64, 2345–2359.
Mautner, V., 2007. Growth and puriﬁcation of enteric adenovirus type 40. Methods Mol. Med. 130, 145–156.
McElrath, M.J., De Rosa, S.C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O.D., Carter, D.K., Hural, J., Akondy, R., Buchbinder, S.P.,
Robertson, M.N., Mehrotra, D.V., Self, S.G., Corey, L., Shiver, J.W., Casimiro, D.R., 2008. HIV-1 vaccine-induced immunity in the test-of-
concept Step Study: a case-cohort analysis. Lancet 372, 1894–1905.
Nevins, J.R., 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424–429.
Obert, S., O'Connor, R.J., Schmid, S., Hearing, P., 1994. The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimer-
ization of a heteromeric E2F complex. Mol. Cell. Biol. 14, 1333–1346.
Priddy, F.H., Brown, D., Kublin, J., Monahan, K., Wright, D.P., Lalezari, J., Santiago, S., Marmor, M., Lally, M., Novak, R.M., Brown, S.J.,
Kulkarni, P., Dubey, S.A., Kierstead, L.S., Casimiro, D.R., Mogg, R., DiNubile, M.J., Shiver, J.W., Leavitt, R.Y., Robertson, M.N.,
Mehrotra, D.V., Quirk, E., 2008. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/
nef vaccine in healthy adults. Clin. Infect. Dis. 46, 1769–1781.
Raychaudhuri, P., Bagchi, S., Neill, S.D., Nevins, J.R., 1990. Activation of the E2F transcription factor in adenovirus-infected cells involves
E1A-dependent stimulation of DNA-binding activity and induction of cooperative binding mediated by an E4 gene product. J. Virol.
64, 2702–2710.
Rothmann, T., Hengstermann, A., Whitaker, N.J., Scheffner, M., zur Hausen, H., 1998. Replication of ONYX-015, a potential anticancer ad-
enovirus, is independent of p53 status in tumor cells. J. Virol. 72, 9470–9478.
Roy, S., Vandenberghe, L.H., Kryazhimskiy, S., Grant, R., Calcedo, R., Yuan, X., Keough, M., Sandhu, A., Wang, Q., Medina-Jaszek, C.A.,
Plotkin, J.B., Wilson, J.M., 2009. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of
non-human primates. PLoS Pathog. 5, e1000503.
Roy, S., Clawson, D.S., Adam, V.S., Medina, A., Wilson, J.M., 2011. Construction of gene transfer vectors based on simian adenovirus 7. J.
Gen. Virol. 92, 1749–1753.
Roy, S., Sandhu, A., Medina, A., Clawson, D.S., Wilson, J.M., 2012. Adenoviruses in fecal samples from asymptomatic rhesus macaques,
United States. Emerg. Infect. Dis. 18, 1081–1088.
Saad, R.S., Demetris, A.J., Lee, R.G., Kusne, S., Randhawa, P.S., 1997. Adenovirus hepatitis in the adult allograft liver. Transplantation 64,
1483–1485.
Saitou, N., Nei, M., 1987. The neighbor-joining method: a newmethod for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406–425.
Treacy, A., Carr, M.J., Dunford, L., Palacios, G., Cannon, G.A., O'Grady, A., Moran, J., Hassan, J., Loy, A., Connell, J., Devaney, D., Kelehan, P.,
Hall, W.W., 2010. First report of sudden death due to myocarditis caused by adenovirus serotype 3. J. Clin. Microbiol. 48, 642–645.
Walsh, M.P., Chintakuntlawar, A., Robinson, C.M., Madisch, I., Harrach, B., Hudson, N.R., Schnurr, D., Heim, A., Chodosh, J., Seto, D., Jones,
M.S., 2009. Evidence of molecular evolution driven by recombination events inﬂuencing tropism in a novel human adenovirus that
causes epidemic keratoconjunctivitis. PLoS One 4, e5635.
Wevers, D., Metzger, S., Babweteera, F., Bieberbach, M., Boesch, C., Cameron, K., Couacy-Hymann, E., Cranﬁeld, M., Gray, M., Harris, L.A.,
Head, J., Jeffery, K., Knauf, S., Lankester, F., Leendertz, S.A., Lonsdorf, E., Mugisha, L., Nitsche, A., Reed, P., Robbins, M., Travis, D.A.,
Zommers, Z., Leendertz, F.H., Ehlers, B., 2011. Novel adenoviruses in wild primates: a high level of genetic diversity and evidence
of zoonotic transmissions. J. Virol. 85, 10774–10784.
Wold, W.S.M., Horwitz, M.S., 2007. Adenoviruses, In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 5th ed. Lippincott–Williams &
Wilkins, Philadelphia, pp. 2395–2436.
Wolfe, N.D., Dunavan, C.P., Diamond, J., 2007. Origins of major human infectious diseases. Nature 447, 279–283.
Wood, D.J., 1988. Adenovirus gastroenteritis. Br. Med. J. (Clin. Res. Ed.) 296, 229–230.
Yamano, S., Tokino, T., Yasuda, M., Kaneuchi, M., Takahashi, M., Niitsu, Y., Fujinaga, K., Yamashita, T., 1999. Induction of transformation
and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA. J. Virol. 73, 10095–10103.
